Actively Recruiting
TDCS Stimulation After Covid-19 Infection
Led by Istanbul Medipol University Hospital · Updated on 2025-05-02
50
Participants Needed
1
Research Sites
113 weeks
Total Duration
On this page
Sponsors
I
Istanbul Medipol University Hospital
Lead Sponsor
A
Alanya Alaaddin Keykubat University
Collaborating Sponsor
AI-Summary
What this Trial Is About
In this study, the effects of bilateral stimulation of the dorsolateral prefrontal cortex (DLPFC) with active tDCS (transcranial direct stimulation/transcranial direct stimulation) on neurocognitive (memory and executive) functions in patients with Covid-19 infection and subjective cognitive complaints, as well as resting-state fMRI In the case of dfMRI, it is aimed to examine the default mode network (DMN) and parietal memory network (PMN) inter- and intra-network connectivity alterations and the hippocampal region connectivity alterations and contribute to the relevant literature.
CONDITIONS
Official Title
TDCS Stimulation After Covid-19 Infection
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Have received a positive value from the COVID-19 RT-PCR test in the last 60 days and turned negative
- Be between the ages of 18 and 50 years
- At least 21 days have passed since the disease onset date
You will not qualify if you...
- Having any neurological or psychiatric disease
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Alanya Alaaddin Keykubat Üniversitesi
Antalya, Turkey (Türkiye)
Actively Recruiting
Research Team
C
Cennet Sena Parlatan, phd Cand
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here